Document is current

Any future updates will be listed below

Prediction of Response to FDA-Approved Targeted Therapy and Immunotherapy in Acute Lymphoblastic Leukemia (ALL)

Crossref DOI link: https://doi.org/10.1007/s11864-024-01237-w

Published Online: 2024-08-05

Published Print: 2024-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark